Skip to main content
Atrás
Watch Compare

Serina Therapeutics, Inc.

Calidad de datos: 100%
SER
NYSE Manufacturing Chemicals
$1.95
▼ $0.08 (-3.71%)
Cap. Mercado: 23.95 M
Precio
$1.95
Cap. Mercado
23.95 M
Rango del Día
$1.93 — $2.03
Rango de 52 Semanas
$1.22 — $7.92
Volumen
76,160
Apertura $2.00
Promedio 50D / 200D
$2.10
7.20% below
Promedio 50D / 200D
$3.94
50.60% below

Quick Summary

Puntos Clave

Revenue declined -2.52% annually over 5 years
Negative free cash flow of -18.01 M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 134.66%
Capital intensive — 45.38% of revenue goes to capex

Crecimiento

Revenue Growth (5Y)
-2.52%
Below sector avg (9.35%)
Revenue (1Y)132.14%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
-1077.04%
Below sector avg (-51.02%)
ROIC-421.53%
Net Margin-14755.38%
Op. Margin-18478.46%

Seguridad

Debt / Equity
N/A
Current Ratio1.31
Interest Coverage-112.78

Valoración

PE (TTM)
-1.25
Above sector avg (-1.98)
P/B Ratio13.61
EV/EBITDAN/A
Dividend YieldN/A

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Manufacturing (44 pares)
Métrica Acción Mediana del Sector
P/E -1.3 -2.0
P/B 13.6 5.1
ROE % -1077.0 -51.0
Net Margin % -14755.4 -150.2
Rev Growth 5Y % -2.5 9.3
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) 132.14% Revenue Growth (3Y) -4.32%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -2.52% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 130,000.0 Net Income (TTM) -19.18 M
ROE -1077.04% ROA -179.66%
Gross Margin N/A Operating Margin -18478.46%
Net Margin -14755.38% Free Cash Flow (TTM) -18.01 M
ROIC -421.53% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 1.31
Interest Coverage -112.78 Asset Turnover 0.01
Working Capital 2.71 M Tangible Book Value 1.76 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1.25 Forward P/E N/A
P/B Ratio 13.61 P/S Ratio 184.24
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -75.21%
Market Cap 23.95 M Enterprise Value 15.33 M
Per Share
EPS (Diluted TTM) -1.91 Revenue / Share 0.01
FCF / Share -1.46 OCF / Share -1.46
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 45.38% FCF Conversion 93.91%
SBC-Adj. FCF -20.07 M Growth Momentum 134.66

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 130,000.0 56,000.0 142,000.0 34,000.0 144,000.0
Net Income -19.18 M -11.14 M -14.80 M -10.46 M -8.68 M
EPS (Diluted) -1.91 -1.51 -13.72 — —
Gross Profit — — 102,000.0 21,000.0 125,000.0
Operating Income -24.02 M -17.05 M -9.89 M -6.98 M -7.93 M
EBITDA — — — — —
R&D Expenses 13.16 M 7.48 M 734,000.0 1.03 M 1.46 M
SG&A Expenses — — — — —
D&A 100,000.0 194,000.0 — — 699,000.0
Interest Expense 213,000.0 526,000.0 4.90 M 3.34 M —
Income Tax 18,000.0 0.0 — — -150,000.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 6.95 M 6.72 M 11.97 M 3.24 M 3.15 M
Total Liabilities 6.99 M 6.22 M 6.61 M 20.56 M 15.03 M
Shareholders' Equity -37,000.0 641,000.0 5.47 M -17.21 M -11.83 M
Total Debt — — — 18.12 M —
Cash & Equivalents 3.06 M 3.67 M 345,000.0 645,000.0 584,000.0
Current Assets 6.08 M 5.68 M 754,000.0 2.45 M 2.23 M
Current Liabilities 3.56 M 2.37 M 5.91 M 10.08 M 8.97 M